Northeast Financial Consultants Inc - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 3 filers reported holding SEATTLE GENETICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Northeast Financial Consultants Inc ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$769,000
-23.6%
3,929
-33.7%
0.07%
-28.9%
Q2 2020$1,007,000
+123.8%
5,929
+52.0%
0.10%
+90.2%
Q1 2020$450,000
+0.9%
3,9000.0%0.05%
+27.5%
Q4 2019$446,000
+33.9%
3,9000.0%0.04%
+17.6%
Q3 2019$333,000
+23.3%
3,9000.0%0.03%
+21.4%
Q2 2019$270,000
-31.8%
3,900
-27.9%
0.03%
-36.4%
Q1 2019$396,0005,4100.04%
Other shareholders
SEATTLE GENETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Baker Brothers Advisors 45,725,556$2,365,840,00020.68%
Lagoda Investment Management, L.P. 398,529$20,620,0007.88%
Matrix Capital Management Company, LP 2,118,000$109,585,0003.72%
Ghost Tree Capital, LLC 300,000$15,522,0003.23%
Sio Capital Management, LLC 100,000$5,174,0002.46%
GREAT POINT PARTNERS LLC 249,500$12,909,0002.31%
Redmile Group, LLC 665,139$34,414,0002.10%
Eventide Asset Management 525,000$27,164,0001.69%
Opus Point Partners Management, LLC 35,093$1,816,0001.66%
Boxer Capital, LLC 125,000$6,468,0001.54%
View complete list of SEATTLE GENETICS INC shareholders